ERS International Congress 2020: Highlights from the Thoracic Surgery and Transplantation Assembly
- Dorina Esendagli1,
- Unmil Shah2,
- Guntug Batihan3,
- Dimitrios Magouliotis4,
- Federica Meloni5,
- Robin Vos6,
- Stefano Elia7 and
- Merel Hellemons8⇑
- 1Chest Diseases Department, Baskent University Hospital, Ankara, Turkey
- 2Heart & Lung Transplant Institute, KIMS, Telangana & Global Hospital, Mumbai, India
- 3Department of Thoracic Sugery, Dr Suat Seren Chest Disease and Chest Surgery Education and Research Center, Izmir, Turkey
- 4Department of Thoracic and Cardiovascular Surgery, University of Thessaly, Larissa, Greece
- 5Dept. Respiratory Diseases, University & IRCCS San Matteo Foundation, Pavia, Italy
- 6Dept. Respiratory Diseases, University Hospitals Leuven and Dept. CHROMETA, BREATHE, KU Leuven, Leuven, Belgium
- 7Department of Thoracic Surgery, Tor Vergata University, Rome, Italy
- 8Department of Pulmonary Medicine, Division of lung Transplantation, Erasmus Medical Center, Rotterdam, the Netherlands
- Merel E. Hellemons, Department of pulmonary medicine, Division of lung transplantation, Erasmus Medical Center, Dr Molewaterplein 40, 3015GD Rotterdam, the Netherlands. E-mail: m.hellemons{at}erasmusmc.nl
Abstract
The thoracic surgery and lung transplantation Assembly of the European Respiratory Society is delighted to present the highlights from the 2020 Virtual International Congress. We have selected four sessions that discussed recent advances in a wide range of topics: From use of robotic surgery in thoracic surgery and extracorporeal life support as a bridge to lung transplantation to lung transplantation in the era of new drugs. The sessions are summarised by early career members in close collaboration with the assembly leadership. We aim to give the reader an update on the highlights of the conference in the fields of thoracic surgery and lung transplantation.
Footnotes
This manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Please open or download the PDF to view this article.
Conflict of interest: Dr. Esendagli has nothing to disclose.
Conflict of interest: Dr. Shah has nothing to disclose.
Conflict of interest: Dr. Batihan has nothing to disclose.
Conflict of interest: Dr. Magouliotis has nothing to disclose.
Conflict of interest: Dr. Meloni has nothing to disclose.
Conflict of interest: Robin Vos is a Senior Clinical Research Fellow of the Research-Foundation Flanders (FWO), his institution has received research grants, but Robin Vos has no conflicts of interest to report regarding the current manuscript
Conflict of interest: Dr. Elia has nothing to disclose.
Conflict of interest: Dr. Hellemons has nothing to disclose.
This is a PDF-only article. Please click on the PDF link above to read it.
- Received October 15, 2020.
- Accepted January 13, 2021.
- ©The authors 2021
This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions{at}ersnet.org